Skip to main content

and
  1. Article

    Open Access

    Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

    Despite improvement in the overall survival of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation, the effects of EGFR tyrosine kinase inhibitor (EGFR-T...

    Michihito Miyagi, Hirohisa Katagiri, Hideki Murata, Junji Wasa in BMC Pulmonary Medicine (2022)